The 10th Go4Europe Conference will be held on October 29th at the Hilton Tel Aviv. Organized by Cukierman Investment House Ltd. and Catalyst Fund, Go4Europe is one of the most prestigious business conferences in Israel, addressing the current issues of raising funds and establishing strategic alliances in Europe. A major part of the conference is focused on the Hi-Tech, Biotech, and Greentech industries.
Go4Europe 2012 will host key decision makers, business representatives and parliamentarians from Israel, Europe and Russia. The long list of senior speakers includes: Dr. Yuval Steinitz - Minister of Finance; Mr. Dan Meridor – Deputy Prime Minister and Minister of Intelligence, Israel; Luc Muller, General Manager - OTTO Group; Rurik Halaby, Chairman – Agricapital Corporation; Alexandre Lupachev, Chief Investment Officer - Skolkovo Foundation; Yossi Gross, Chairman – Rainbow Medical; Bob Lieberman, Head of Innovation & Development - Linde Healthcare; Roger Cukierman - Former CEO - Ed. de Rothschild & Director - Cukierman & Co.; Dr. Florent Gros, Managing Director – Novartis Venture Funds; Technology Guru, Mr. Yossi Vardi;Chaim Teichholtz,CEO – Alcatel Lucent Israel and other business sector representatives and decision makers.
Conference panels will deal with issues such as: Cross border financing models; Financial restructuring strategies and process; Investing opportunities and fundraising in Europe; What's the next step in the telecom, media and internet world?; Innovative deals and business models in the Medical Device Ecosystem; Challenges & opportunities in Green Economy; RethinkingBig Pharma and Biotech's Approach to Niche Markets; The image of Israel in Europe. The Go4Russia panel will be dedicated to strengthening Russia-Israel business ties.
A special panel of Elevator Pitches will include 12 selected innovative technology companies, given the opportunity to briefly introduce their products to potential investors.
The Cukierman Investment House and Catalyst Fund are to award Michael Federmann, the Chairman of Federmann Enterprises, a special honor for his far reaching contribution to the Israeli industry and the relationship between Israel and Europe.
Edouard Cukierman, Chairman of Cukierman & Co. Investment House and managing partner of Catalyst Fund: "This year's conference calls for new rules in European-Israeli business relationship, based on innovation in both - R&D and financing models. Europe is eager for innovation as this is the key to restart growth, and Israeli technology companies can make the perfect partners. As for financing, the changing economic scene requires to adopt innovative models such as: cross border financing and financial restructuring, to be discussed in the Conference amongst other subjects.
"Israel's major trade partner has always been Europe, which is still the biggest market in the world in terms of purchasing power parity."
Cukierman & Co. is a leading European focused investment house, with a strong international network to many leading European corporations and financial institutions. Headquartered in Israel, the company provides a full array of investment banking services including: Corporate Finance, Private Equity, Family Office and Strategic Consulting to Israeli and European companies. Specialties include Life science, Technologies Media & Telecom, Green technologies and Real estate. Catalyst Funds are Israeli-based private equity funds investing in mature Israeli companies. Catalyst has recently established 2 funds for emerging markets, including Catalyst III - a Bilateral PE Fund between Russia and Israel, with Rusnano Capital as an anchor investor; and Catalyst IV – for Israeli companies that want to expand their activity into China.
For further information visit: www.go4eu.com.Business Wire
Last updated on: 10/10/2012
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.